228 related articles for article (PubMed ID: 25415199)
21. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH
J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302
[TBL] [Abstract][Full Text] [Related]
22. Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation.
Lemarie A; Morzadec C; Mérino D; Micheau O; Fardel O; Vernhet L
J Pharmacol Exp Ther; 2006 Jan; 316(1):304-14. PubMed ID: 16174796
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface.
Benbijja M; Mellouk A; Bobé P
Mol Cancer; 2014 Nov; 13():251. PubMed ID: 25410152
[TBL] [Abstract][Full Text] [Related]
24. [Arsenic trioxide enhances TRAIL inducing human lung cancer cell line A549 cells apoptosis by down-regulate the expression of NF-kappaB].
Wang JY; Zhao XQ; Wang CM; Mo BW; Jiang M; Chen F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):834-8. PubMed ID: 23387208
[TBL] [Abstract][Full Text] [Related]
25. [Homoharringtonine combined arsenic trioxide induced apoptosis in human multiple myeloma cell line RPMI 8226: an experimental research].
Zhou XJ; Zhou YH; Chen XH; Qian WB
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):834-9. PubMed ID: 23980369
[TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway.
Scholz C; Richter A; Lehmann M; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2005 Oct; 24(47):7031-42. PubMed ID: 16007134
[TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide and bortezomib interact synergistically to induce apoptosis in chronic myelogenous leukemia cells resistant to imatinib mesylate through Bcr/Abl‑dependent mechanisms.
Xu W; Wei W; Yu Q; Wu C; Ye C; Wu Y; Yan H
Mol Med Rep; 2014 Sep; 10(3):1519-24. PubMed ID: 24939418
[TBL] [Abstract][Full Text] [Related]
28. Telomere attrition and chromosome instability via downregulation of TRF2 contributes to arsenic trioxide-induced apoptosis of human T-Cell leukemia cell line molt-4 cells.
Jiao Y; Zhang W; Liu J; Ni W; Xu W; Jin J; Qian W
Cancer Biol Ther; 2007 Aug; 6(8):1186-92. PubMed ID: 17643074
[TBL] [Abstract][Full Text] [Related]
29. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
30. Gossypol suppresses NF-kappaB activity and NF-kappaB-related gene expression in human leukemia U937 cells.
Moon DO; Kim MO; Lee JD; Kim GY
Cancer Lett; 2008 Jun; 264(2):192-200. PubMed ID: 18314260
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide induces gallbladder carcinoma cell apoptosis via downregulation of Bcl-2.
Ai Z; Lu W; Qin X
Biochem Biophys Res Commun; 2006 Sep; 348(3):1075-81. PubMed ID: 16904648
[TBL] [Abstract][Full Text] [Related]
32. [Study of triptolide-induced apoptosis in MUTZ-1 cells and its allied mechanism].
Deng J; Jin J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):434-9. PubMed ID: 15972136
[TBL] [Abstract][Full Text] [Related]
33. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
[TBL] [Abstract][Full Text] [Related]
34. Antitumor efficacy of DMSA modified Fe3O4 magnetic nanoparticles combined with arsenic trioxide and adriamycin in Raji cells.
Cai X; Cai X; Wang C; Chen B; Hua W; Shen F; Yu L; He Z; Shi Y; Chen Y; Xia G; Bao W; Zhang Y; Wang X
J Biomed Nanotechnol; 2014 Feb; 10(2):251-61. PubMed ID: 24738333
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of human papillomavirus E6/E7 oncogene by arsenic trioxide in cervical carcinoma cells.
Um SJ; Lee SY; Kim EJ; Myoung J; Namkoong SE; Park JS
Cancer Lett; 2002 Jul; 181(1):11-22. PubMed ID: 12430174
[TBL] [Abstract][Full Text] [Related]
36. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
Chen G; Wang K; Yang BY; Tang B; Chen JX; Hua ZC
Int J Oncol; 2012 Jan; 40(1):139-47. PubMed ID: 21947421
[TBL] [Abstract][Full Text] [Related]
37. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines.
Mukhopadhyay A; Bueso-Ramos C; Chatterjee D; Pantazis P; Aggarwal BB
Oncogene; 2001 Nov; 20(52):7597-609. PubMed ID: 11753638
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of As2O3 induces apoptosis of glioma U87 cells.
Wang GB; Liu JH; Hu J; Xue K
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4875-4881. PubMed ID: 29164574
[TBL] [Abstract][Full Text] [Related]
39. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
Wang X; Wang G; Dong D; Fu S; Yang B
Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide represses NF-kappaB activation and increases apoptosis in ATRA-treated APL cells.
Mathieu J; Besançon F
Ann N Y Acad Sci; 2006 Dec; 1090():203-8. PubMed ID: 17384263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]